{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:17:22Z","timestamp":1776867442559,"version":"3.51.2"},"reference-count":21,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Wroclaw Research Center EIT+","award":["01.01.02-02-003\/08-00"],"award-info":[{"award-number":["01.01.02-02-003\/08-00"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vaccine.2018.06.037","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T06:41:19Z","timestamp":1530168079000},"page":"4641-4649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cyclic OmpC peptidic epitope conjugated to tetanus toxoid as a potential vaccine candidate against shigellosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Anna","family":"Jarz\u0105b","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danuta","family":"Witkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund","family":"Ziomek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Setner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Czajkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Dorot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew","family":"Szewczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Gamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.06.037_b0005","doi-asserted-by":"crossref","first-page":"e1264","DOI":"10.1371\/journal.pntd.0001264","article-title":"A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children","author":"Vinh","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.06.037_b0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2046-4053-1-39","article-title":"Effectiveness of rifaximin and fluoroquinolones in preventing travelers\u2019 diarrhea (TD): a systematic review and meta-analysis","volume":"1","author":"Alajbegovic","year":"2012","journal-title":"Syst Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2018.06.037_b0015","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1371\/journal.pone.0000361","article-title":"Dipstick for rapid diagnosis of Shigella flexneri 2a in stool","volume":"2","author":"Nato","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.037_b0020","unstructured":"WHO Initiative for Vaccine Research (IVR). Diarrhoeal diseases; 2009. <http:\/\/www.who.int\/vaccine_research\/diseases\/diarrhoeal\/en\/index.html>."},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.037_b0025","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/IAI.68.3.1034-1039.2000","article-title":"Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans","volume":"68","author":"Kotloff","year":"2000","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2018.06.037_b0030","doi-asserted-by":"crossref","first-page":"e22663","DOI":"10.1371\/journal.pone.0022663","article-title":"Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model","volume":"6","author":"Pore","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.037_b0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1574-695X.2006.00137.x","article-title":"Enterobacterial 38-kDa outer membrane protein is an age-dependent molecular marker of innate immunity and immunoglobulin deficiency as results from its reactivity with IgG and IgA antibody","volume":"48","author":"Witkowska","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2018.06.037_b0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jmb.2006.08.002","article-title":"Crystal structure of osmoporin OmpC from E. coli at 2.0 A","volume":"362","author":"Basl\u00e9","year":"2006","journal-title":"J Mol Biol"},{"issue":"8","key":"10.1016\/j.vaccine.2018.06.037_b0045","doi-asserted-by":"crossref","first-page":"e70539","DOI":"10.1371\/journal.pone.0070539","article-title":"Shigella flexneri 3a outer membrane protein C epitope recognized by human umbilical cord sera and associated with protective activity","volume":"8","author":"Jarz\u0105b","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.037_b0050","first-page":"39","article-title":"Potential carrier for conjugate vaccines: OMP-38 protein from Shigella flexnerii 3a \u2013 isolation and purification strategies","volume":"4","author":"Jarz\u0105b","year":"2011","journal-title":"Sepsis"},{"key":"10.1016\/j.vaccine.2018.06.037_b0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/prep.2002.1619","article-title":"A rapid selective extraction procedure for the outer membrane protein (OmpF) from Escherichia coli","volume":"25","author":"Arcidiacono","year":"2002","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2018.06.037_b0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2018.06.037_b0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1385\/0-89603-274-4:207","article-title":"Epitope mapping of a protein using the Geysen (PEPSCAN) procedure","volume":"36","author":"Carter","year":"1994","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.037_b0070","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0003-2697(66)90275-2","article-title":"Determination of free amino groups in proteins by trinitrobenzenesulfonic acid","volume":"14","author":"Habeeb","year":"1966","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2018.06.037_b0075","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2018.06.037_b0080","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1128\/jb.169.9.4003-4010.1987","article-title":"Lipopolysaccharide tightly bound to porin monomers and trimers from Escherichia coli K-12","volume":"169","author":"Rocque","year":"1987","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2018.06.037_b0085","series-title":"Cellular and molecular aspects of endotoxin reactions","first-page":"145","article-title":"A critical determinant of lipid A endotoxic activity","author":"Myers","year":"1990"},{"key":"10.1016\/j.vaccine.2018.06.037_b0090","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1038\/srep06008","article-title":"Serum stable natural peptides designed by mRNA display","volume":"4","author":"Howell","year":"2014","journal-title":"Sci Rep."},{"issue":"9","key":"10.1016\/j.vaccine.2018.06.037_b0095","doi-asserted-by":"crossref","first-page":"e12684","DOI":"10.1371\/journal.pone.0012684","article-title":"Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs","volume":"5","author":"Nguyen","year":"2010","journal-title":"PLoS One"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2018.06.037_b0100","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0264-410X(98)00385-5","article-title":"A new method of non-cross-linking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide-protein conjugate vaccines","volume":"17","author":"Pawlowski","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.037_b0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00063030-200721030-00002","article-title":"Epitope mapping: the first step in developing epitope-based vaccines","volume":"21","author":"Gershoni","year":"2007","journal-title":"BioDrugs"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830865X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830865X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:42Z","timestamp":1759400862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1830865X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":21,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0264410X1830865X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclic OmpC peptidic epitope conjugated to tetanus toxoid as a potential vaccine candidate against shigellosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}